Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
8th Dec 20219:50 amRNSAquisition of Praxis Fund Services by Sanne Group
3rd Dec 20217:00 amRNSCompany Update
2nd Dec 20213:12 pmRNSNet Asset Value(s)
2nd Dec 20213:12 pmRNS2019 Redemption Portfolio
30th Nov 20214:00 pmRNSTotal Voting Rights
24th Nov 20211:04 pmRNSDirector/PDMR Shareholding
5th Nov 20215:06 pmRNSReturn of Capital to Shareholders
2nd Nov 20214:18 pmRNS2019 Redemption Portfolio
2nd Nov 20214:17 pmRNSNet Asset Value(s)
28th Oct 202112:31 pmRNSResult of AGM
7th Oct 202111:51 amRNSHolding(s) in Company
7th Oct 20217:00 amRNSNotice of AGM
6th Oct 202111:50 amRNSHolding(s) in Company
1st Oct 20211:11 pmRNSNet Asset Value(s)
1st Oct 202112:55 pmRNS2019 Redemption Portfolio
20th Sep 20213:48 pmRNSHalf-year Report
14th Sep 20212:21 pmRNSDirector/PDMR Shareholding
1st Sep 20212:58 pmRNS2019 Redemption Portfolio
1st Sep 20212:55 pmRNSNet Asset Value(s)
31st Aug 20214:40 pmRNSHolding(s) in Company
27th Aug 20217:00 amRNSHolding(s) in Company
19th Aug 20214:00 pmRNSTotal Voting Rights
12th Aug 20214:00 pmRNSReturn of Capital to Shareholders
4th Aug 20215:07 pmRNS2019 Redemption Portfolio
4th Aug 202110:23 amRNSNet Asset Value(s)
27th Jul 20219:15 amRNSDirector Declaration
5th Jul 202112:15 pmRNSApproximate Asset Exposure of the Company
29th Jun 20214:44 pmRNS2019 Redemption Portfolio
29th Jun 20214:38 pmRNSNet Asset Value - Month End Final
21st Jun 20218:31 amRNSDirector/PDMR Shareholding
28th May 20214:30 pmRNSTotal Voting Rights
27th May 20217:00 amRNSHolding(s) in Company
25th May 20214:57 pmRNS2019 Redemption Portfolio
25th May 20214:54 pmRNSNet Asset Value - Month End Final
25th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 202112:54 pmRNSReturn of Capital to shareholders
6th May 20214:48 pmRNSNet Asset Value - Month End Final
6th May 20214:48 pmRNS2019 Redemption Portfolio
22nd Apr 20213:24 pmRNSReturn of Capital to Shareholders
22nd Apr 20217:00 amRNSAnnual Report and Financial Statements
25th Mar 20215:15 pmRNS2019 Redemption Portfolio
25th Mar 20215:14 pmRNSNet Asset Value - Month End Final
5th Mar 20214:51 pmRNS2019 Redemption Portfolio
5th Mar 20214:50 pmRNSNet Asset Value - Month End Final
26th Feb 20214:20 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20214:38 pmRNSReturn of Capital to Shareholders
19th Feb 20211:10 pmRNSNet Asset Value - Weekly Estimate
18th Feb 20215:12 pmRNSHolding(s) in Company
16th Feb 20211:48 pmRNSNet Asset Value - Weekly Estimate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.